This Tiny Plastic Implant May Disrupt America’s Opioid Addiction Problem

Motherboard by Vice, November 15, 2016. “I think the big issue is the transition,” said Diana Zuckerman, NCHR President, who was not involved with the trials. “People are going to go from taking pills to using this implant. The implant doesn’t work immediately. It takes a while for it to work and settle into the level that it’s supposed to be. And during that time the person is still going to be taking pills, and that becomes a vulnerable time. How many pills should that person take before the implant is really working, and should they continue to take pills after it’s working?“

Read More »

FDA Hearing on Off-Labels Use of Devices Explores Risks to Patients

Star Tribune, November 10, 2016. NCHR President Diana Zuckerman said the Infuse Bone Graft is “contraindicated” for children. But the FDA’s 2015 warning didn’t ban the product in kids because some children have such significant bone defects or such rare bone disorders that they would be willing to accept the risks.

Read More »